These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24989269)

  • 1. [Significance of CD37 expression in malignant B cells].
    Wang W; Li Y; Gao L; Xu SH; Gong M; Huang FZ; Li ZL; Chen YR; Ma YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):644-7. PubMed ID: 24989269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
    Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
    Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.
    Pereira DS; Guevara CI; Jin L; Mbong N; Verlinsky A; Hsu SJ; Aviña H; Karki S; Abad JD; Yang P; Moon SJ; Malik F; Choi MY; An Z; Morrison K; Challita-Eid PM; Doñate F; Joseph IB; Kipps TJ; Dick JE; Stover DR
    Mol Cancer Ther; 2015 Jul; 14(7):1650-60. PubMed ID: 25934707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
    Bobrowicz M; Kubacz M; Slusarczyk A; Winiarska M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD37 expression in follicular lymphoma.
    Yoshimura T; Miyoshi H; Shimono J; Nakashima K; Takeuchi M; Yanagida E; Yamada K; Shimasaki Y; Moritsubo M; Furuta T; Kohno K; Ohshima K
    Ann Hematol; 2022 May; 101(5):1067-1075. PubMed ID: 35171311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates.
    Bartsch R; Arland M; Lange S; Kahl C; Valet G; Höffkes HG
    Cytometry; 2000 Sep; 41(1):9-18. PubMed ID: 10942891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD37 protects against the development of B cell lymphoma.
    de Winde CM; Veenbergen S; Young KH; Xu-Monette ZY; Wang XX; Xia Y; Jabbar KJ; van den Brand M; van der Schaaf A; Elfrink S; van Houdt IS; Gijbels MJ; van de Loo FA; Bennink MB; Hebeda KM; Groenen PJ; van Krieken JH; Figdor CG; van Spriel AB
    J Clin Invest; 2016 Feb; 126(2):653-66. PubMed ID: 26784544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.
    Witkowska M; Smolewski P; Robak T
    Expert Opin Investig Drugs; 2018 Feb; 27(2):171-177. PubMed ID: 29323537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispectral imaging reveals the tissue distribution of tetraspanins in human lymphoid organs.
    de Winde CM; Zuidscherwoude M; Vasaturo A; van der Schaaf A; Figdor CG; van Spriel AB
    Histochem Cell Biol; 2015 Aug; 144(2):133-46. PubMed ID: 25952155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiparameter flow cytometric evaluation of bone marrow involvement in B cell non-Hodgkin's lymphoma].
    Wan SG; Sun XJ; Hui WH; He JJ; Liu CY; Zhao H; Sun WL; Su L; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):473-6. PubMed ID: 20416192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD37 targeted immunotherapy of B-Cell malignancies.
    Payandeh Z; Noori E; Khalesi B; Mard-Soltani M; Abdolalizadeh J; Khalili S
    Biotechnol Lett; 2018 Dec; 40(11-12):1459-1466. PubMed ID: 30293139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma.
    Elfrink S; Ter Beest M; Janssen L; Baltissen MP; Jansen PWTC; Kenyon AN; Steen RM; de Windt D; Hagemann PM; Hess C; van Spronsen DJ; Hoevenaars B; van der Spek E; Xu-Monette ZY; Young KH; Kaffa C; Bervoets S; van Heek J; Hesius E; de Winde CM; Vermeulen M; van den Brand M; Scheijen B; van Spriel AB
    Blood Adv; 2022 Apr; 6(7):2254-2266. PubMed ID: 35086136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of bone marrow involvement by lymphoma cells in patients with B-NHL by using flow cytometry analysis].
    Wang W; Gao L; Wang LL; Li MY; Li YY; Zhao W; Xu YY; Ding Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1204-7. PubMed ID: 21129261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
    Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
    Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.